Semaglutide for Weight Loss
Research, mechanism, dosing, and effectiveness of Semaglutide for weight loss.
Quick Answer
Semaglutide is FDA-approved and clinically proven for weight loss. STEP trials showed average weight loss of 15-17% of body weight - one of the most effective pharmaceutical interventions available.
Evidence Level
FDA Approved
Typical Dose
0.25mg weekly increasing to 2.4mg weekly over 16-20 weeks
Results Timeline
Noticeable weight loss within 4 weeks, significant results by 3-6 months
FDA Status
FDA Approved
How Semaglutide Works for Weight Loss
Mimics GLP-1 hormone to reduce appetite, slow gastric emptying, and act on brain satiety centers. Creates a sustained feeling of fullness.
About Weight Loss
Reduction of body fat and overall body weight through appetite control and metabolic enhancement.
Research Evidence
STEP trials: 15-17% weight loss. FLOW trial: 24% reduction in kidney disease progression (Jan 2025 approval). Wegovy pill: 16.6% weight loss (Dec 2025 approval). Oral Rybelsus approved for CV risk reduction (Oct 2025). In January 2025, Ozempic received FDA approval for reducing kidney disease progression in T2D patients with CKD. In March 2026, Wegovy HD (7.2mg) was approved, delivering 20.7% mean weight loss — the highest for any injectable semaglutide dose.
Dosing for Weight Loss
Recommended Dose
0.25mg weekly increasing to 2.4mg weekly over 16-20 weeks
Frequency
Once weekly
Administration
Subcutaneous injection weekly, or oral (Rybelsus)
Duration
Long-term / chronic use
Note: Titrate up slowly over 16-20 weeks to minimize GI side effects. Start at 0.25 mg, increase every 4 weeks. Many stay at 1 mg if tolerating well.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Nausea (common, usually transient)
- •Vomiting
- •Diarrhea
- •Constipation
- •Abdominal pain
- •Headache
Frequently Asked Questions
Does Semaglutide help with weight loss?
Semaglutide is FDA-approved and clinically proven for weight loss. STEP trials showed average weight loss of 15-17% of body weight - one of the most effective pharmaceutical interventions available.
How does Semaglutide work for weight loss?
Mimics GLP-1 hormone to reduce appetite, slow gastric emptying, and act on brain satiety centers. Creates a sustained feeling of fullness....
What dose of Semaglutide should I use for weight loss?
0.25mg weekly increasing to 2.4mg weekly over 16-20 weeks
How long until I see results?
Noticeable weight loss within 4 weeks, significant results by 3-6 months
Other Peptides for Weight Loss
These peptides are also researched for weight loss.
Tirzepatide
FDAA dual GIP/GLP-1 receptor agonist representing the next generation of incretin-based therapies. Shows superior weight loss compared to semaglutide in head-to-head trials. First medication approved for obstructive sleep apnea.
Retatrutide
Clinical TrialsA triple agonist targeting GLP-1, GIP, and glucagon receptors. Phase 3 trials show up to 28.7% weight loss (71 lbs average), the highest of any obesity drug. Expected FDA approval late 2026 to early 2027.
AOD-9604
Clinical TrialsA modified fragment of human growth hormone (amino acids 177-191) studied for fat metabolism effects without the broader hormonal effects of full GH.
Liraglutide
FDAAn FDA-approved GLP-1 receptor agonist for type 2 diabetes and chronic weight management. The predecessor to semaglutide with daily dosing.